Results 1 to 10 of about 4,463 (168)

Pimecrolimus for the Treatment of Atopic Dermatitis in Infants: An Asian Perspective

Dermatology and Therapy, 2023
Atopic dermatitis (AD) is a common chronic, multisystem inflammatory skin disease in pediatric patients. There has been an increase in the incidence of AD in the pediatric population of the Asia–Pacific region. Studies have shown that genetic, epigenetic,
Chia-Yu Chu, Tsung-Chieh Yao, I.-Hsin Shih, Chin-Yi Yang, Chan Lee Chin, Sabeera Begum Binti Kader Ibrahim, Suganthi Thevarajah, Leong Kin Fon, Marco Hok-Kung Ho, Chow Chung Mo, Chow Pok Yu, Steven King-Fan Loo, Thomas Luger   +12 more
doaj   +2 more sources

Pimecrolimus interferes the therapeutic efficacy of human mesenchymal stem cells in atopic dermatitis by regulating NFAT-COX2 signaling

Stem Cell Research & Therapy, 2021
Background Human mesenchymal stem cells (hMSCs) therapy has recently been considered a promising treatment for atopic dermatitis (AD) due to their immunomodulation and tissue regeneration ability.
Nari Shin, Namhee Jung, Seung-Eun Lee, Dasom Kong, Nam Gyo Kim, Myung Geun Kook, Hwanhee Park, Soon Won Choi, Seunghee Lee, Kyung-Sun Kang   +9 more
doaj   +2 more sources

Microneedling in Combination with Topical Pimecrolimus 1% versus Topical Pimecrolimus 1% for the Treatment of Refractory Stable Vitiligo: A Randomized Clinical Trial

Dermatology Research and Practice, 2021
Objective. Vitiligo is a common, autoimmune disease that results in the destruction of the melanocytes and manifests as depigmented macules on various areas of the skin. Numerous treatment options have been proposed for vitiligo.
Fariba Iraji, Ali Asilian, Zahra Talebzadeh, Mina Saber, Fatemeh Mokhtari, Amirhossein Siadat, Seyed Mohsen Hosseini   +6 more
doaj   +2 more sources

Comparative evaluation of pimecrolimus cream 1% and triamcinolone aceonide paste in treatment of atrophic–Erosive oral lichen planus

Journal of Pharmacy and Bioallied Sciences, 2023
Objectives: This study was done to assess the effects of pimecrolimus cream 1% and triamcinolone aceonide paste in the treatment of atrophic–erosive oral lichen planus.
Atul Anand Bajoria, Sangamesh Ningappa Chinnannavar, Silpiranjan Mishra, Dhirendra K Singh, Jugajyoti Pathi, Vikash K Jha   +5 more
doaj   +2 more sources

Antiviral activity of pimecrolimus against dengue virus type 2 infection in vitro and in vivo

Scientific Reports
Dengue virus (DENV) infection is a public health concern in several countries and is associated with severe diseases, such as dengue hemorrhagic fever and dengue shock syndrome.
Seong-Ryeol Kim, Jung-Min Lee, Hae Ji Kang, Jungsang Ryou, Sang-Mu Shim   +4 more
doaj   +2 more sources

Effects of mycophenolate mofetil, methotrexate and pimecrolimus on cdk4 and p16 in erosive oral lichen planus

Indian Journal of Dermatology, 2021
Background: This study evaluated the effect of mycophenolate mofetil, methotrexate, and pimecrolimus on the expression of cdk4 and p16, important proteins implicated in hyperproliferation and arrest in the G1 phase, in oral lichen planus (OLP). Materials
Sinny Goel, Nita Khurana
doaj   +2 more sources

Practical recommendations for seborrheic dermatitis management: An expert consensus. [PDF]

J Eur Acad Dermatol Venereol
This modified Delphi study established expert consensus on Seborrheic Dermatitis management. Key findings prioritize combined topical antifungal and anti‐inflammatory therapy for both acute flares and long‐term maintenance. The consensus also provides a clear framework for escalating to systemic treatment in extensive or refractory cases.
Naldi L, Kyrgidis A, Tiplica GS, de Rie MA, Tatsis D, Gisondi P, Ioannides D, Chosidow O, Deleuran M, Delphi SD study experts.   +9 more
europepmc   +2 more sources

Observational study of pimecrolimus 1% cream for prevention of transcutaneous sensitization in children with atopic dermatitis during their first year of life

Frontiers in Pediatrics, 2023
IntroductionEpidermal barrier dysfunction in children with atopic dermatitis can cause transcutaneous sensitization to allergens and allergic diseases.
Nikolay N. Murashkin, Nikolay N. Murashkin, Nikolay N. Murashkin, Nikolay N. Murashkin, Leyla S. Namazova-Baranova, Leyla S. Namazova-Baranova, Svetlana G. Makarova, Roman A. Ivanov, Stepan G. Grigorev, Stepan G. Grigorev, Dmitri V. Fedorov, Eduard T. Ambarchian, Eduard T. Ambarchian, Roman V. Epishev, Roman V. Epishev, Alexander I. Materikin, Leonid A. Opryatin, Alena A. Savelova   +17 more
doaj   +2 more sources

The effects of Chinese botanical lotion and pimecrolimus cream in the treatment of chronic perianal eczema: a randomized clinical trial [PDF]

Frontiers in Pharmacology
BackgroundFumigation and sitz-bath therapy are traditional Chinese medicine (TCM) practices that offer unique benefits for managing chronic perianal eczema (CPE).
Lixia Lai, Yanmei Wang, Luping Wen, Shaozhao Wang, Si Chen, Chao Gu, Zeye Zhang   +6 more
doaj   +2 more sources

Topical Calcineurin Inhibitors in Rosacea: Potential Benefit in Selected Clinical Settings and Risk of Rosaceiform Dermatitis [PDF]

Clinical, Cosmetic and Investigational Dermatology
Tingwei Liu,1 Xiaoqi Meng,1 Nuoran Chen,1 Wanqing Yang,1 Dansheng Li,1,2 Yang Xu11Department of Dermatology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, People’s Republic of China; 2Department of Dermatology, Beilun ...
Liu T, Meng X, Chen N, Yang W, Li D, Xu Y   +5 more
doaj   +2 more sources